Immunohistochemistry of thrombi following iliac venous stenting

A novel model of venous thrombosis

Bobby Burches, Krzysztof Karnicki, Waldemar Wysokinski, Robert D. McBane

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Stenting has become a common intervention for venous occlusive disease. Little is known regarding the composition of venous thrombi complicating stent placement. The optimal design of antithrombotic agents in this setting requires this knowledge. Quantitative immunohistochemistry was undertaken to define the platelet, fibrin(ogen) and leukocyte composition and spatial orientation of venous thrombi following percutaneous iliac stent placement in pigs. Venous stent thrombus size was measured by weight and scintillation detection of autologous 111In-platelets. Thrombi were divided in segments (cephalad to caudad), sectioned and stained with monoclonal anti-platelet glycoprotein lb or polyclonal anti-fibrin(ogen) fluorescent antibodies. Thrombus platelet content was 100-fold greater than paired whole blood samples. The caudal-most segments contained platelet-rich aggregates (p<0.05) with abundant leukocytes (p<0.0001) relative to more cephalad segments. Platelet and fibrin(ogen) content varied over an eight-fold range between segments but were directly correlated with each other (r=0.77; p<0.0001).The platelet co-localization with fibrin(ogen) is consistent with the phospholipid dependence of prothrombin activation. The abundance and caudal distribution of platelet-leukocyte aggregates indicate their preferential accretion from flowing blood early in the genesis of venous stent thrombi. These may represent novel cellular targets for the prevention and treatment of venous thrombosis.

Original languageEnglish (US)
Pages (from-to)618-622
Number of pages5
JournalThrombosis and Haemostasis
Volume96
Issue number5
DOIs
StatePublished - Nov 2006

Fingerprint

Venous Thrombosis
Thrombosis
Blood Platelets
Immunohistochemistry
Fibrin
Stents
Leukocytes
Platelet Membrane Glycoproteins
Fibrinolytic Agents
Prothrombin
Phospholipids
Swine
Weights and Measures
estropipate
Antibodies

Keywords

  • Platelets
  • Vascular stents
  • Venous thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Immunohistochemistry of thrombi following iliac venous stenting : A novel model of venous thrombosis. / Burches, Bobby; Karnicki, Krzysztof; Wysokinski, Waldemar; McBane, Robert D.

In: Thrombosis and Haemostasis, Vol. 96, No. 5, 11.2006, p. 618-622.

Research output: Contribution to journalArticle

Burches, Bobby ; Karnicki, Krzysztof ; Wysokinski, Waldemar ; McBane, Robert D. / Immunohistochemistry of thrombi following iliac venous stenting : A novel model of venous thrombosis. In: Thrombosis and Haemostasis. 2006 ; Vol. 96, No. 5. pp. 618-622.
@article{c700004dac6f43b7b8c2d7917c6b088a,
title = "Immunohistochemistry of thrombi following iliac venous stenting: A novel model of venous thrombosis",
abstract = "Stenting has become a common intervention for venous occlusive disease. Little is known regarding the composition of venous thrombi complicating stent placement. The optimal design of antithrombotic agents in this setting requires this knowledge. Quantitative immunohistochemistry was undertaken to define the platelet, fibrin(ogen) and leukocyte composition and spatial orientation of venous thrombi following percutaneous iliac stent placement in pigs. Venous stent thrombus size was measured by weight and scintillation detection of autologous 111In-platelets. Thrombi were divided in segments (cephalad to caudad), sectioned and stained with monoclonal anti-platelet glycoprotein lb or polyclonal anti-fibrin(ogen) fluorescent antibodies. Thrombus platelet content was 100-fold greater than paired whole blood samples. The caudal-most segments contained platelet-rich aggregates (p<0.05) with abundant leukocytes (p<0.0001) relative to more cephalad segments. Platelet and fibrin(ogen) content varied over an eight-fold range between segments but were directly correlated with each other (r=0.77; p<0.0001).The platelet co-localization with fibrin(ogen) is consistent with the phospholipid dependence of prothrombin activation. The abundance and caudal distribution of platelet-leukocyte aggregates indicate their preferential accretion from flowing blood early in the genesis of venous stent thrombi. These may represent novel cellular targets for the prevention and treatment of venous thrombosis.",
keywords = "Platelets, Vascular stents, Venous thrombosis",
author = "Bobby Burches and Krzysztof Karnicki and Waldemar Wysokinski and McBane, {Robert D.}",
year = "2006",
month = "11",
doi = "10.1106/Th06-07-0364",
language = "English (US)",
volume = "96",
pages = "618--622",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "5",

}

TY - JOUR

T1 - Immunohistochemistry of thrombi following iliac venous stenting

T2 - A novel model of venous thrombosis

AU - Burches, Bobby

AU - Karnicki, Krzysztof

AU - Wysokinski, Waldemar

AU - McBane, Robert D.

PY - 2006/11

Y1 - 2006/11

N2 - Stenting has become a common intervention for venous occlusive disease. Little is known regarding the composition of venous thrombi complicating stent placement. The optimal design of antithrombotic agents in this setting requires this knowledge. Quantitative immunohistochemistry was undertaken to define the platelet, fibrin(ogen) and leukocyte composition and spatial orientation of venous thrombi following percutaneous iliac stent placement in pigs. Venous stent thrombus size was measured by weight and scintillation detection of autologous 111In-platelets. Thrombi were divided in segments (cephalad to caudad), sectioned and stained with monoclonal anti-platelet glycoprotein lb or polyclonal anti-fibrin(ogen) fluorescent antibodies. Thrombus platelet content was 100-fold greater than paired whole blood samples. The caudal-most segments contained platelet-rich aggregates (p<0.05) with abundant leukocytes (p<0.0001) relative to more cephalad segments. Platelet and fibrin(ogen) content varied over an eight-fold range between segments but were directly correlated with each other (r=0.77; p<0.0001).The platelet co-localization with fibrin(ogen) is consistent with the phospholipid dependence of prothrombin activation. The abundance and caudal distribution of platelet-leukocyte aggregates indicate their preferential accretion from flowing blood early in the genesis of venous stent thrombi. These may represent novel cellular targets for the prevention and treatment of venous thrombosis.

AB - Stenting has become a common intervention for venous occlusive disease. Little is known regarding the composition of venous thrombi complicating stent placement. The optimal design of antithrombotic agents in this setting requires this knowledge. Quantitative immunohistochemistry was undertaken to define the platelet, fibrin(ogen) and leukocyte composition and spatial orientation of venous thrombi following percutaneous iliac stent placement in pigs. Venous stent thrombus size was measured by weight and scintillation detection of autologous 111In-platelets. Thrombi were divided in segments (cephalad to caudad), sectioned and stained with monoclonal anti-platelet glycoprotein lb or polyclonal anti-fibrin(ogen) fluorescent antibodies. Thrombus platelet content was 100-fold greater than paired whole blood samples. The caudal-most segments contained platelet-rich aggregates (p<0.05) with abundant leukocytes (p<0.0001) relative to more cephalad segments. Platelet and fibrin(ogen) content varied over an eight-fold range between segments but were directly correlated with each other (r=0.77; p<0.0001).The platelet co-localization with fibrin(ogen) is consistent with the phospholipid dependence of prothrombin activation. The abundance and caudal distribution of platelet-leukocyte aggregates indicate their preferential accretion from flowing blood early in the genesis of venous stent thrombi. These may represent novel cellular targets for the prevention and treatment of venous thrombosis.

KW - Platelets

KW - Vascular stents

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33751236782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751236782&partnerID=8YFLogxK

U2 - 10.1106/Th06-07-0364

DO - 10.1106/Th06-07-0364

M3 - Article

VL - 96

SP - 618

EP - 622

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 5

ER -